Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackson T Wright

Showing results (141-150 of 189) with videos related to

Pageof 19
Sort By:
Journal of the American Heart Association|July 17, 2019
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINTLama Ghazi, Nicholas M Pajewski, Dena E Rifkin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 17, 2020
Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial)Rakesh Malhotra, Ronit Katz, Vasantha Jotwani, et al.
American Journal of Hypertension|April 27, 2017
Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency CohortFaraz S Ahmad, Xuan Cai, Katherine Kunkel, et al.
JAMA Cardiology|October 12, 2022
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical TrialByron C Jaeger, Adam P Bress, Joshua D Bundy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2012
Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFRMahboob Rahman, Charles E Ford, Jeffrey A Cutler, et al.
The New England Journal of Medicine|November 10, 2015
A Randomized Trial of Intensive versus Standard Blood-Pressure Control, Jackson T Wright, Jeff D Williamson, et al.
Hypertension (Dallas, Tex. : 1979)|January 28, 2020
Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINTStephen P Juraschek, Addison A Taylor, Jackson T Wright, et al.
American Journal of Hypertension|October 7, 2017
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical TrialCarolyn H Still, Carlos J Rodriguez, Jackson T Wright, et al.
Clinical Trials (London, England)|June 7, 2014
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)Walter T Ambrosius, Kaycee M Sink, Capri G Foy, et al.
The New England Journal of Medicine|May 19, 2021
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control, Cora E Lewis, Lawrence J Fine, et al.
Pageof 19

Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Journal of the American Heart Association|July 17, 2019
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINTLama Ghazi, Nicholas M Pajewski, Dena E Rifkin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 17, 2020
Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial)Rakesh Malhotra, Ronit Katz, Vasantha Jotwani, et al.
American Journal of Hypertension|April 27, 2017
Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency CohortFaraz S Ahmad, Xuan Cai, Katherine Kunkel, et al.
JAMA Cardiology|October 12, 2022
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical TrialByron C Jaeger, Adam P Bress, Joshua D Bundy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2012
Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFRMahboob Rahman, Charles E Ford, Jeffrey A Cutler, et al.
The New England Journal of Medicine|November 10, 2015
A Randomized Trial of Intensive versus Standard Blood-Pressure Control, Jackson T Wright, Jeff D Williamson, et al.
Hypertension (Dallas, Tex. : 1979)|January 28, 2020
Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINTStephen P Juraschek, Addison A Taylor, Jackson T Wright, et al.
American Journal of Hypertension|October 7, 2017
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical TrialCarolyn H Still, Carlos J Rodriguez, Jackson T Wright, et al.
Clinical Trials (London, England)|June 7, 2014
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)Walter T Ambrosius, Kaycee M Sink, Capri G Foy, et al.
The New England Journal of Medicine|May 19, 2021
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control, Cora E Lewis, Lawrence J Fine, et al.
Pageof 19